Skip to main content

Weather alert

Due to Hurricane Isaias, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Editorial: New Insights: Developments in Laboratory Testing for the Diagnosis and Monitoring of Endocrine Related Disorders and Metabolic Disease

Editorial: New Insights: Developments in Laboratory Testing for the Diagnosis and Monitoring of Endocrine Related Disorders and Metabolic Disease

Authors: Gounden V, Tanpaiboon P

Citation: Front Endocrinol (Lausanne). 2024 Nov 29;15:1524950. doi: 10.3389/fendo.2024.1524950.

Specialties: Cardiology, Endocrinology

Related content

Audio Podcast
The Cardiometabolic Approach: A Solution to Modern Disease Risk Assessment
Audio Podcast
Instant Insight: Metabolic Risk Panel
Audio Podcast
Laboratory Testing for the Diagnosis and Management of Thyroid Disorders
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.